The CDK12 gene helps cells switch on long stretches of DNA, including many genes that repair everyday DNA damage. When it does not work well, cells may struggle to fix DNA properly, which can let changes build up and increase the chance of some cancers, especially in the breast, ovary, and prostate. Many variants are harmless, while a few may change how the gene supports stable cell growth.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or regulating activities in the body. Some genes carry the code for proteins, the working parts of cells. Others mainly direct when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, and medications. For a deeper look at this topic, you can learn more in the LearnHub.
Overview
CDK12Gene function
What if the gene works
The CDK12 gene helps cells read certain genes fully, especially ones used for DNA repair. It also supports stable gene activity and normal cell growth.
Risk
What if the gene does not work
Milder variants in the CDK12 gene may partly reduce control of gene transcription, while more severe variants can more strongly disrupt activation of DNA repair genes. This can impair RNA processing and make cells less able to maintain stable DNA.
Treatment
What does that mean for your treatment
No treatment approach specific to the CDK12 gene is currently established in clinical guidelines. In cancer care, pathogenic or loss-of-function variants in the CDK12 gene are being studied as biomarkers that may help predict response to some treatments, including immune checkpoint inhibitors and certain targeted drugs, but this use is not yet standard.
Gene function
What if the gene works
Your cells use the CDK12 gene to keep gene activity organized and steady. It helps the cell read certain long, important genes and finish their RNA messages properly. Understanding what the CDK12 gene does in your cells helps explain how many routine repair and upkeep tasks stay on track.
The CDK12 gene makes an enzyme, a protein that adds small chemical tags to other proteins. These tags help the cell's gene reading machinery work in a controlled, orderly way.
Its protein helps cells keep reading long genes from start to finish. This allows full RNA messages to be made instead of incomplete copies.
CDK12 also supports RNA processing, the step where a fresh genetic message is edited and prepared for use. It helps with splicing (editing the message) and making a proper RNA end.
Many genes guided by the CDK12 gene make proteins used for DNA repair and routine cell maintenance. By supporting those messages, it helps cells protect and manage their genetic instructions.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CDK12 gene can weaken the protein, shorten it, or alter the part that binds its partner cyclin K, which may reduce kinase activity and make the protein less stable. Milder CDK12 gene variants may partly lower activity, while more severe variants can stop the protein from being made or leave it unable to work. These changes can also disturb how the protein interacts with other cell machinery and how long it lasts inside the cell.
How variants are linked to conditions
Variants in the CDK12 gene are most clearly linked to certain cancers, especially when the change is found in tumor cells rather than inherited. Research on CDK12 gene variants and cancer risk is strongest for prostate, ovarian, and some breast cancers. Inherited variants are still under study, so a CDK12 finding does not by itself explain or predict cancer for most people.
A variant is not necessarily a diagnosis
Variants in genes are a routine part of human biology and are widely found in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental influences are involved. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the CDK12 gene. Risk can vary depending on the exact gene change and whether it is inherited or found only in tumor cells, so personal guidance from a doctor or genetic counselor can help put results in context.
Inheritance of CDK12 variants
There is not yet a broadly confirmed, disease specific inheritance pattern for the CDK12 gene, so how CDK12 gene variants are inherited in relation to health conditions is still being clarified. Research on this gene is ongoing, and understanding may become more precise over time. The CDK12 gene is located on chromosome 17, which is an autosome. That means each person inherits one copy of the CDK12 gene from their mother and one from their father.
What does my CDK12 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific inherited condition for CDK12, though this can become clearer as research grows. If you have a specific CDK12 result and want to understand what it could mean for close relatives, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
To find a variant in the CDK12 gene, CDK12 genetic testing reads the gene’s DNA code from a blood, saliva, or tissue sample. A lab compares the sequence with the usual version and reports any variant it finds. Results may show a clearly relevant variant, a benign change, or an uncertain finding.
When should I consider getting a genetic test?
There is not yet a broadly established reason to order CDK12 testing on its own. If you or close relatives have a strong history of breast, ovarian, or prostate cancer, a doctor or genetic counselor may discuss whether CDK12 belongs on a larger inherited cancer panel.
A genetic result is only one part of your health story
Genetic results can provide useful insight, but how much they reveal depends on the condition and on the kind of variant involved. Over time, many factors shape how the body functions, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, it can also help place personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work well for one person but less well for another. These differences can change how a drug is absorbed, broken down, or moved through the body, which may influence how much benefit you get or how sensitive you are to side effects. This is a common part of human biology and helps explain why medication response is often individual.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies patterns between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed, individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the CDK12 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding everyday medication choices, so questions about symptoms, side effects, or treatment changes are best discussed with your doctor. In cancer care, CDK12 changes in a tumor are being studied for possible links to response to some treatments, but this is not a standard prescribing guide.
History
In recent decades, awareness of this gene’s role has grown. The CDK12 gene was identified in the early 2000s during efforts to map and classify human cell cycle related kinases, a family of genes involved in basic cell regulation. As medical science evolved, so did understanding of this gene, and researchers later recognized CDK12 as important in cancer studies, especially in ovarian and prostate cancer. Interest increased as large sequencing projects began finding CDK12 variants in some tumors, which helped place it on the list of genes doctors and researchers now watch more closely in precision cancer medicine. Over time, descriptions became more precise, moving CDK12 from a little known research gene to one with clear relevance in modern cancer genetics.